← FDA Drug Approvals (Drugs@FDA)

ATOVAQUONE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HETERO LABS LTD III · Approved 2018-10-11

Drug application

FDA Application #

ANDA210692

Application type

Abbreviated New Drug Application (Generic)

Brand name

ATOVAQUONE

Generic name

ATOVAQUONE

Active ingredients

ATOVAQUONE

Dosage form

SUSPENSION

Route

ORAL

Marketing status

Prescription

Sponsor

HETERO LABS LTD III

Manufacturer

Camber Pharmaceuticals, Inc.

First approval

2018-10-11

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown